tiprankstipranks
Nufarm Limited (AU:NUF)
ASX:NUF
Want to see AU:NUF full AI Analyst Report?

Nufarm Limited (NUF) AI Stock Analysis

63 Followers

Top Page

AU:NUF

Nufarm Limited

(Sydney:NUF)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
AU$2.50
▲(3.73% Upside)
Action:ReiteratedDate:12/12/25
Nufarm Limited's overall stock score reflects significant financial challenges, including declining revenues and profitability issues. The technical analysis indicates bearish momentum, and the valuation is unattractive due to a negative P/E ratio. However, the earnings call highlighted some positive strategic initiatives and debt reduction efforts, which provide a glimmer of hope for future improvement.
Positive Factors
Crop Protection Momentum
An 18% earnings uplift and margin expansion in the core Crop Protection business reflects durable demand and execution across geographies. As Nufarm's primary revenue engine, sustained strength here supports long-term cash generation, margin resilience and funding for strategic priorities.
Negative Factors
Statutory Loss / Impairments
Large non-cash write-downs and a statutory loss signal structural asset revaluation and portfolio issues, reducing equity and future earnings capacity. Impairments often reflect fundamental problems in business segments that can weigh on returns and strategic optionality over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Crop Protection Momentum
An 18% earnings uplift and margin expansion in the core Crop Protection business reflects durable demand and execution across geographies. As Nufarm's primary revenue engine, sustained strength here supports long-term cash generation, margin resilience and funding for strategic priorities.
Read all positive factors

Nufarm Limited (NUF) vs. iShares MSCI Australia ETF (EWA)

Nufarm Limited Business Overview & Revenue Model

Company Description
Nufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. It operates through two segments, Crop Prote...
How the Company Makes Money
Nufarm primarily makes money by selling crop protection products (including herbicides, insecticides, fungicides, and seed treatments) to agricultural customers via distributors, retailers, and, in some markets, direct-to-farm channels. Revenue is...

Nufarm Limited Earnings Call Summary

Earnings Call Date:Nov 18, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 27, 2026
Earnings Call Sentiment Neutral
The earnings call highlights a strong performance in Crop Protection and a strategic repositioning in Seed Technologies. However, significant losses from material items and challenges in the omega-3 market offset these positives. The company is focusing on debt reduction and operational improvements for future growth.
Positive Updates
Strong Crop Protection Performance
Crop Protection delivered a strong result with an 18% increase in earnings and profitability growth across all regions. EBITDA margin improved by 140 basis points.
Negative Updates
Statutory Loss Due to Material Items
A statutory loss of $165 million was reported, including $142 million of mainly non-cash material items related to the Seed Technology review and performance improvement program.
Read all updates
Q4-2025 Updates
Negative
Strong Crop Protection Performance
Crop Protection delivered a strong result with an 18% increase in earnings and profitability growth across all regions. EBITDA margin improved by 140 basis points.
Read all positive updates
Company Guidance
During the Nufarm Limited FY '25 Results Conference Call, several key metrics and strategic directions were highlighted. The company reported a statutory loss of $165 million, influenced by $142 million in non-cash material items and a broader performance improvement program. Despite this, Crop Protection saw an 18% increase in earnings, with an EBITDA margin improvement of 140 basis points and growth across all regions. Net debt was reduced by $538 million, ending with a leverage ratio of 2.7x. The company anticipates strong EBITDA growth in FY '26, targeting a leverage of 2.0x and planning for capital expenditure below $200 million. Seed Technologies underwent a strategic review, resulting in a reprioritized strategy aimed at enhancing shareholder value, focusing on profitable hybrid seeds, a reduction in omega-3 cash requirements, and expansion in bioenergy with BP. The outlook for FY '26 includes continued growth in Crop Protection, a $30 million improvement in emerging platforms' EBITDA, and a commitment to strong cost and capital deployment discipline.

Nufarm Limited Financial Statement Overview

Summary
Nufarm Limited is facing financial headwinds with declining revenues, profitability challenges, and increased leverage. The company experienced a significant revenue decline of 17.87% and a negative net profit margin of -4.80%. Despite a reasonable gross profit margin, operational inefficiencies are evident with low EBIT and EBITDA margins. The balance sheet shows moderate leverage, but the negative return on equity and declining cash flow metrics highlight potential liquidity challenges.
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
50
Neutral
BreakdownSep 2025Sep 2024Sep 2023Sep 2022Jul 2021
Income Statement
Total Revenue3.44B3.35B3.48B3.77B3.22B
Gross Profit950.13M840.37M1.03B972.59M834.71M
EBITDA158.37M263.77M427.18M421.60M359.18M
Net Income-165.32M-5.60M111.14M107.44M65.13M
Balance Sheet
Total Assets4.58B4.43B4.63B4.66B4.37B
Cash, Cash Equivalents and Short-Term Investments474.72M463.56M410.96M585.70M724.22M
Total Debt1.30B1.10B1.26B931.87M1.04B
Total Liabilities2.47B2.22B2.32B2.51B2.25B
Stockholders Equity2.11B2.21B2.31B2.15B2.12B
Cash Flow
Free Cash Flow41.17M219.43M-352.36M160.20M281.70M
Operating Cash Flow162.76M472.39M-125.62M359.57M424.19M
Investing Cash Flow-245.61M-207.46M-241.73M-240.41M-146.30M
Financing Cash Flow83.87M-200.76M185.98M-264.37M19.18M

Nufarm Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.41
Price Trends
50DMA
2.08
Positive
100DMA
2.21
Positive
200DMA
2.29
Positive
Market Momentum
MACD
0.10
Negative
RSI
65.26
Neutral
STOCH
72.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUF, the sentiment is Positive. The current price of 2.41 is above the 20-day moving average (MA) of 2.12, above the 50-day MA of 2.08, and above the 200-day MA of 2.29, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 65.26 is Neutral, neither overbought nor oversold. The STOCH value of 72.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NUF.

Nufarm Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
AU$874.79M8.3217.82%0.88%3.42%54.50%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
49
Neutral
AU$898.92M-5.30-7.66%2.91%-620.97%
45
Neutral
AU$33.33M-1.75-102.56%24.22%40.08%
44
Neutral
AU$19.76M-1.63-56.43%-25.56%38.24%
43
Neutral
AU$244.55M10.410.27%6.76%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NUF
Nufarm Limited
2.34
-1.55
-39.85%
AU:CP8
Fertoz
0.12
0.09
300.00%
AU:WGN
Wagners Holding Co. Ltd.
4.38
2.71
162.43%
AU:TGH
Terragen Holdings Ltd
0.02
>-0.01
-20.00%
AU:RLF
RLF AgTech Ltd
0.06
0.02
55.00%
AU:PLA
Pacific Lime and Cement Limited
0.29
0.06
29.55%

Nufarm Limited Corporate Events

Nufarm Performance Rights Lapse After Conditions Not Met
Apr 16, 2026
Nufarm Limited has notified the market that 59,577 performance rights, trading under the ASX security code NUFAA, have lapsed. The lapse occurred because the conditions attached to these conditional rights were not met or have become incapable of ...
Nufarm lifts earnings, cuts debt and targets extra $50m in cost savings
Apr 14, 2026
Nufarm reported a strong first-half performance for FY26, with underlying EBITDA expected between $239 million and $244 million, driven by higher Crop Protection margins, growth in Hybrid Seeds and improved omega-3 and bioenergy platforms. Net deb...
Nufarm Issues 2.9 Million Unquoted Performance Rights Under Incentive Scheme
Apr 14, 2026
Nufarm Limited has notified the market of the issue of 2,915,497 unquoted performance rights under its employee incentive scheme, with an issue date of March 31, 2026. The new performance rights, which are not intended to be quoted on the ASX, for...
Host-Plus Exits Substantial Shareholding in Nufarm
Apr 7, 2026
Host-Plus Pty Limited has notified Nufarm Limited that it has ceased to be a substantial shareholder in the company as of 31 March 2026, in line with disclosure requirements under the Corporations Act. The filing indicates that there have been cha...
Nufarm Extends bp Biofuels Pact to 2050 to Scale Carinata Feedstock
Mar 25, 2026
Nufarm has expanded its long-term strategic partnership with bp to scale production of Carinata, a non-food oilseed crop used as a sustainable feedstock for aviation fuel and renewable diesel. The updated offtake and marketing agreement, now exten...
Nufarm Director Adrian Percy Increases Shareholding Through On-Market Purchase
Feb 24, 2026
Nufarm Limited has disclosed a change in the shareholding of director Adrian Percy, who increased his direct holding in the company through an on-market purchase. Percy acquired 15,500 additional ordinary shares for about USD24,800 at an average p...
Nufarm Issues New Performance Rights Under Employee Incentive Scheme
Feb 24, 2026
Nufarm Limited has notified the market of the issue of 279,046 unquoted performance rights under its employee incentive scheme, with an issue date of 19 February 2026. The additional equity-based awards, which are not intended to be quoted on the ...
Nufarm Shareholders Back Board, CEO Incentives, and Constitution Change
Feb 4, 2026
At its 2026 AGM, Nufarm secured strong shareholder backing for every resolution, including the adoption of its remuneration report, the re-election of directors John Gillam, Alexandra Gartmann, and Marie McDonald, equity rights for the incoming CE...
Nufarm Flags Strong Underlying Crop Protection Performance Despite FY25 Statutory Loss
Feb 3, 2026
Nufarm used its 2026 Annual General Meeting to outline a mixed FY25 performance, acknowledging a statutory loss of $165 million largely driven by $142 million of mainly non-cash items tied to a strategic review and repositioning of its Seed Techno...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 12, 2025